Contract Bidding Open For Leucoverin 15mg Tab,Tab Morphine Hydrochloride 30 Mg,Morphine Hydrocloride 10 mg Tab,Olaparib 100 m in PANCHKULA, HARYANA
Progress
Quantity
36565
Categories
7
A tender has been published for Indian Army Leucoverin 15mg Tab, Tab Morphine Hydrochloride 30 Mg, Morphine Hydrocloride 10 mg Tab, Olaparib 100 mg Tab, Actinomycin 0. 5 mg Inj, Inj Bleomycin Sulphate Chloride 15 mg, Carboplatin 450mg Inj, Lomustine 40 mg Tab, Carboplatin 150 mg Inj, Cisplatin 10mg Inj, Dacarbazine 200mg Inj, Inj Doxorubicin HCl 2mg ml 5ml, Epirubicin HCl 10mg Inj, Inj Etoposide 100mg 5ml Vial, Inj 5 Fluorouracil 500mg 10ml, Erlotinib 150mg Tab, Inj Ifosfamide 1 gm Mesna, Docetaxel 80mg 2ml vial of 6 ml solvent for Inj, Inj Gemcitabine 1000 mg, Inj Gemcitabine 200mg, Irinotecan 100mg Inj, Pegylated Liposomal Doxorubicin 20mg Inj, Procarbazine HCl 50mg Cap, Vincristine Sulphate 1mg Inj, Leucovorin Calcium 50mg ml Inj, Mesna 200mg Inj, Inj Vinorelbine 10 mg, Tab Biclutamide 50mg, Exemestane 25 mg Tab, Letrozole 2. 5 mg Tab, Anastrazole 1 mg Tab, Tab Everolimus 10 m g, Inj Pegylated GCSF 6MG, Inj Cetuximab 100 mg, Pemetrexed 500 mg Powder for Inj, Pazopanib 200mg Tab, Tab Lenvatinib 4Mg, Lenvatinib 10 mg Tab, Ado Trastuzumab Emtansine TDM 1 vial of 100 mg Inj, Inj Ramucirumab 500 mg 50 ml vial, Nano Liposomal Docetaxel vial of 20 mg Inj, Non coring chemoport needle 20 G 22 G Pack of one needle, Inj Fosaprepitant 150 MG, Pemetrexed 100 mg Inj, Buprenorphine Path 10 MCG, Tegafur 100 mg plus Uracil 224 mg Cap, Aprepitant 1 Cap 125 Mg and 2 Cap 80 Mg, Albumin bound Paclitaxel 100 mg Inj, Morphine CR 30 mg tab, Bendamustin 100 mg Inj, Denosumab 120mg Inj, Irinotecan 40mg Inj, Inj Leucovorin 15 mg, Tab Abemaciclib 200 Mg, Tab Capecitabine 400 mgplusCyclophaspamide 20mg, Tab Enzalutamide 160 mg, Tab Tepotinib 225 mg, Tab Enzalutamide 80 mg, Cap Tegafur 15 mg and Gimeracil 4. 35 mg and Otearacil 11. 8 mg, Inj Phesgo subcutaneous pertuzumab 600mg plus Inj Trastuzumab 600mg with hyaluronidose, Inj Phesgo subcutaneous pertuzumab 1200mg plus Inj Trastuzumab 600mg with hyaluronidose, Tab Rucaparib 300mg, Tab Rucaparib 200 mg, Inj Bevacizumab 300 mg, Tab Cabozantinib 60 mg, Tab Alpelisib 150 Mg, Tab Alpelisib 200 Mg, Inj Trastuzumab deruxtecan 100 mg, BRENTUXIAMAB VEDOTIN 50 MG VAIL, Inj Cyclophosphamide 500 mg, Temozolamide 100mg Cap, Tamoxifen Citrate 20 mg Tab, Pazopenib 400mg Tab, Inj Cyclophosphamide 1 gm in PANCHKULA, HARYANA. Quantity: 36565 by. Submission Deadline: 10-01-2025 17: 00: 00. Check eligibility and apply.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Leucoverin 15mg Tab , Tab Morphine Hydrochloride 30 Mg , Morphine Hydrocloride 10 mg Tab , Olaparib 100 mg Tab , Actinomycin 0.5 mg Inj , Inj Bleomycin Sulphate Chloride 15 mg , Carboplatin 450mg Inj , Lomustine 40 mg Tab , Carboplatin 150 mg Inj , Cisplatin 10mg Inj , Dacarbazine 200mg Inj , Inj Doxorubicin HCl 2mg ml 5ml , Epirubicin HCl 10mg Inj , Inj Etoposide 100mg 5ml Vial , Inj 5 Fluorouracil 500mg 10ml , Erlotinib 150mg Tab , Inj Ifosfamide 1 gm Mesna , Docetaxel 80mg 2ml vial of 6 ml solvent for Inj , Inj Gemcitabine 1000 mg , Inj Gemcitabine 200mg , Irinotecan 100mg Inj , Pegylated Liposomal Doxorubicin 20mg Inj , Procarbazine HCl 50mg Cap , Vincristine Sulphate 1mg Inj , Leucovorin Calcium 50mg ml Inj , Mesna 200mg Inj , Inj Vinorelbine 10 mg , Tab Biclutamide 50mg , Exemestane 25 mg Tab , Letrozole 2.5 mg Tab , Anastrazole 1 mg Tab , Tab Everolimus 10 m g , Inj Pegylated GCSF 6MG , Inj Cetuximab 100 mg , Pemetrexed 500 mg Powder for Inj , Pazopanib 200mg Tab , Tab Lenvatinib 4Mg , Lenvatinib 10 mg Tab , Ado Trastuzumab Emtansine TDM 1 vial of 100 mg Inj , Inj Ramucirumab 500 mg 50 ml vial , Nano Liposomal Docetaxel vial of 20 mg Inj , Non coring chemoport needle 20 G 22 G Pack of one needle , Inj Fosaprepitant 150 MG , Pemetrexed 100 mg Inj , Buprenorphine Path 10 MCG , Tegafur 100 mg plus Uracil 224 mg Cap , Aprepitant 1 Cap 125 Mg and 2 Cap 80 Mg , Albumin bound Paclitaxel 100 mg Inj , Morphine CR 30 mg tab , Bendamustin 100 mg Inj , Denosumab 120mg Inj , Irinotecan 40mg Inj , Inj Leucovorin 15 mg , Tab Abemaciclib 200 Mg , Tab Capecitabine 400 mgplusCyclophaspamide 20mg , Tab Enzalutamide 160 mg , Tab Tepotinib 225 mg , Tab Enzalutamide 80 mg , Cap Tegafur 15 mg and Gimeracil 4.35 mg and Otearacil 11.8 mg , Inj Phesgo subcutaneous pertuzumab 600mg plus Inj Trastuzumab 600mg with hyaluronidose , Inj Phesgo subcutaneous pertuzumab 1200mg plus Inj Trastuzumab 600mg with hyaluronidose , Tab Rucaparib 300mg , Tab Rucaparib 200 mg , Inj Bevacizumab 300 mg , Tab Cabozantinib 60 mg , Tab Alpelisib 150 Mg , Tab Alpelisib 200 Mg , Inj Trastuzumab deruxtecan 100 mg , BRENTUXIAMAB VEDOTIN 50 MG VAIL , Inj Cyclophosphamide 500 mg , Temozolamide 100mg Cap , Tamoxifen Citrate 20 mg Tab , Pazopenib 400mg Tab , Inj Cyclophosphamide 1 gm
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7277899.pdf
Main Document
View File
Referenced Document
Buyer uploaded ATC document Click here to view the file .
Referenced Document
attached categories, trials are allowed as per approved procurement policy of the buyer nodal Ministries)
Referenced Document
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Corrigendum Updates
1 Update Update
Extended Deadline
13-Jan-2025, 9:00 am
Opening Date
13-Jan-2025, 9:30 am
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 10-01-2025 16:53:54 | |
| 2 | ********** Under PMA | - | 11-01-2025 11:44:50 | |
| 3 | ********** Under PMA | - | 10-01-2025 14:34:14 | |
| 4 | ********** Under PMA | - | 11-01-2025 20:18:30 | |
| 5 | ********** Under PMA | - | 10-01-2025 16:49:07 | |
| 6 | ********** Under PMA | - | 11-01-2025 12:26:09 | |
| 7 | ********** Under PMA | - | 10-01-2025 12:42:12 | |
| 8 | ********** Under PMA | - | 09-01-2025 18:03:20 | |
| 9 | ********** Under PMA | - | 09-01-2025 17:06:12 | |
| 10 | ********** Under PMA | - | 10-01-2025 16:24:34 | |
| 11 | ********** Under PMA | - | 10-01-2025 16:36:44 | |
| 12 | ********** Under PMA | - | 10-01-2025 16:26:35 | |
| 13 | ********** Under PMA | - | 10-01-2025 16:21:07 | |
| 14 | ********** Under PMA | - | 10-01-2025 13:23:09 | |
| 15 | ********** Under PMA | - | 09-01-2025 14:47:43 | |
| 16 | ********** Under PMA | - | 08-01-2025 15:11:43 | |
| 17 | ********** Under PMA | - | 10-01-2025 14:42:29 | |
| 18 | ********** Under PMA | - | 10-01-2025 16:57:44 | |
| 19 | ********** Under PMA | - | 10-01-2025 16:03:53 | |
| 20 | ********** Under PMA | - | 09-01-2025 14:15:58 | |
| 21 | ********** Under PMA | - | 09-01-2025 14:02:04 | |
| 22 | ********** Under PMA | - | 07-01-2025 14:21:10 | |
| 23 | ********** Under PMA | - | 10-01-2025 16:38:02 | |
| 24 | ********** Under PMA | - | 10-01-2025 15:13:31 |
Frequently Asked Questions
Key insights about HARYANA tender market
What are the eligibility requirements for participating in this tender?
The eligibility requirements include being a registered entity with a minimum average annual turnover of 143 Lakh for the last three financial years and having at least three years of past experience in providing similar products to government entities.
What documents are required for bidding?
Bidders must submit documentation including their past performance records, experience criteria, bidder turnover verification, required certificates as outlined in the ATC, and compliance documents verifying adherence to the BoQ specifications.
How is the registration process carried out for the tender?
The registration process involves ensuring that the bidding entity is registered in accordance with the local laws and complies with any specific registration criteria set forth by the Department of Military Affairs.
Which document formats are acceptable for submission?
Accepted document formats typically include PDF, DOC, and other standard formats as specified in the tender documents. Bidders should ensure that all documentation is clear and legible.
What are the technical specifications for the required oncology drugs?
Technical specifications include adherence to the provided BoQ detailing each drug's formulation, dosage, and compliance with health regulations. Full specifications are available in the tender documentation.
Are there specific quality standards that must be met?
Yes, all products must comply with regulatory requirements and quality standards as defined in the relevant legal frameworks and specifications outlined in the tender.
What compliance requirements should bidders be aware of?
Bidders must comply with all legal and regulatory provisions applicable to pharmaceutical supplies, including quality certifications and adherence to the guidelines set forth by the Ministry of Defence.
What is the Earnest Money Deposit (EMD) for this tender?
The Earnest Money Deposit (EMD) is 63, which must be submitted along with the bid to demonstrate commitment to the tender terms.
What are the performance security requirements after bid acceptance?
Post-bid acceptance, successful bidders are required to furnish a performance bank guarantee (PBG) equivalent to 3% of the contract value, valid for 24 months.
How will the payment terms be structured?
Payment terms will be detailed in the contract and typically include milestones based on delivery schedules and acceptance of goods as compliant with the specifications.
What price evaluation considerations should bidders keep in mind?
Bidders should prepare competitive pricing proposals, taking into account all technical compliance requirements and the potential for reverse auction rounds that will determine the final pricing dynamics of the tender.
How will submission methods be handled?
Bids must be submitted electronically through the GeM portal, ensuring that all required documents are attached and compliant with specified submission standards.
What are the key timelines and deadlines for this tender?
Specific timelines and deadlines will be indicated in the tender documentation, and bidders should check the document for any updates or specific instructions regarding submission.
How will the evaluation and selection process be conducted?
The evaluation process will be item-wise, ensuring that all bids are analyzed based on technical compliance, historical performance, and pricing strategies, concluding with a potential reverse auction among the qualified bidders.
When will the results of the tender be communicated to the bidders?
The results will be communicated as specified in the tender documentation, usually following the completion of the evaluation and selection process. Bidders should monitor the GeM portal for updates.
What benefits are available for Micro, Small, and Medium Enterprises (MSEs)?
MSEs are exempt from specific experience and turnover criteria, provided they can prove compliance with quality standards and technical specifications required in the tender.
Are there provisions for startups in this tender?
No, startups do not receive exemptions from experience and turnover criteria and must meet all requirements as stipulated in the tender.
Does this tender comply with 'Make in India' policies?
Yes, the tender adheres to the 'Make in India' policies, encouraging local sourcing and preference for local suppliers meeting the defined local content requirements outlined in the tender documentation.
What are the local content and procurement rules applicable?
Local content rules specify a minimum percentage of local sourcing that must be met for products; bidders are required to provide certifications regarding local content to prove eligibility for purchase preference.
These FAQs provide a thorough understanding of the requirements and processes relevant to GEM/2024/B/5732548, aiming to clarify common queries for potential bidders.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7277899.pdf
Main Document
View File
Referenced Document
Buyer uploaded ATC document Click here to view the file .
Referenced Document
attached categories, trials are allowed as per approved procurement policy of the buyer nodal Ministries)
Referenced Document